siRNA JNJ-73763989 decreases HBsAg and HDV RNA in NA-treated hepatitis D patients but may cause ALT flares

Journal:

Journal of Hepatology

Published:

2026-05-15

DOI:

10.1016/j.jhep.2026.05.007

Affiliations:

19

Authors:

18

Go to article

Institutions	Authors	Share
Johnson & Johnson, Belgium, Belgium	4.000000	0.22
Johnson & Johnson, United States of America (USA)	2.000000	0.11
The University of Auckland, New Zealand	1.000000	0.06
King's College Hospital NHS Foundation Trust, United Kingdom (UK)	1.000000	0.06
Istanbul University Cerrahpaşa (IUC), Turkey	1.000000	0.06
Biomedical Research Networking Center in Hepatic and Digestive Diseases (CIBEREHD), Spain	1.000000	0.06
Ege University, Turkey	1.000000	0.06
Hepatologist Medical Company, Samara, Russia	1.000000	0.06
Karolinska University Hospital, Sweden	1.000000	0.06
KTU Farabi Hospital International, Turkey	1.000000	0.06
Janssen Research & Development, LLC (J&J PRD), United States of America (USA)	1.000000	0.06
August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Spain	0.500000	0.03
Vall d'Hebron University Hospital (HUVH), ICS, Spain	0.500000	0.03
IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Italy	0.500000	0.03
University of Milan (UNIMI), Italy	0.500000	0.03
Hannover Medical School (MHH), Germany	0.333333	0.02
Cluster of Excellence RESIST (EXC 2155), Germany	0.333333	0.02
DZIF Partner Site Hannover-Braunschweig, Germany	0.333333	0.02

Interested in Medical Microbiology?